Skip to content
Lower risk Drug recall · FDA · Published February 5, 2024

Sun Pharmaceutical Mesalamine Capsules Recall: Failed Dissolution Specifications

Sun Pharmaceutical recalls 500mg Mesalamine Extended-Release Capsules due to failed dissolution specifications. This may affect drug effectiveness. Check NDC 63304-089-13 and lot numbers for affected batches.

🇺🇸 FDA recall #D-0350-2024DrugSun Pharmaceutical ›
Take action

Contact the company

Recalling firmSUN PHARMACEUTICAL INDUSTRIES INC2 Independence Way · Princeton, NJ 08540-6620
✎ GovInfoNow plain-language explainer

Sun Pharmaceutical is recalling 500mg Mesalamine Extended-Release Capsules because they failed dissolution tests. This could mean the medication doesn't work properly when taken as intended. Read more at govinfonow.com/recall/32835-sun-pharmaceutical-mesalamine-capsules-recall-failed-dissolution-specifications.

Source Summary by GovInfoNow · govinfonow.com/recall/32835-sun-pharmaceutical-mesalamine-capsules-recall-failed-dissolution-specifications · Updated September 23, 2026 · FDA enforcement record: FDA #D-0350-2024

Cite this page

“Sun Pharmaceutical Mesalamine Capsules Recall: Failed Dissolution Specifications.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/32835-sun-pharmaceutical-mesalamine-capsules-recall-failed-dissolution-specifications. Based on FDA recall #D-0350-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0350-2024%22&limit=1).

The FDA announced on Feb. 5, 2024, that Sun Pharmaceutical is recalling Mesalamine Extended-Release Capsules due to failed dissolution specifications. The agency issued recall number D-0350-2024 for the voluntary Class II action.

How to tell if you have it

  • Brand: Sun Pharmaceutical
  • Product: Mesalamine Extended-Release Capsules, USP 500mg, Rx Only, 120 Capsules per bottle
  • NDC: 63304-089-13
  • Lot codes: MHD0606A, MHD0612A (Exp. 04/30/2024); MHD0613A, MHD0652A, MHD0657A, MHD0672A, MHD0673A (Exp. 05/31/2024); MHD0767A, MHD0768A, MHD0769A, MHD0785A, MHD0799A, MHD0800A, MHD0801A (Exp. 06/30/2024); MHD0827A, MHD0828A, MHD0875A, MHD0876A, MHD0898A, MHD0901A (Exp. 07/31/2024); MHD1081A, MHD1082A, MHD1087A (Exp. 09/30/2024)
  • Quantity: 54,960 bottles
  • Distribution: Nationwide in the U.S.

The hazard

The recall addresses Mesalamine Extended-Release Capsules that are out of specification for dissolution. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show SUN PHARMACEUTICAL INDUSTRIES INC has 93 other recalls on record since 2013-05-21. Other recent recalls of similar products include Sun Pharmaceutical Nystatin Cream Recall (2026-09-14), Sun Pharmaceutical Carbamazepine Tablets Recall (2026-08-03), and Sun Pharmaceutical Perampanel 6mg Tablets Recall (2026-06-17). Other recent recalls of similar products include Harvard Drug Group Memantine Capsules Recall (2026-03-24), AvKARE Amantadine Capsules Recall (2026-02-13), and Supernus Trokendi XR 50mg Capsules: Failed Dissolution Specifications Recall (2026-08-31).

How to tell if you have this one

Check the product label for NDC 63304-089-13 and lot numbers like MHD0606A through MHD1087A with specific expiration dates listed in the recall notice.

  • Brand
    Sun Pharmaceutical
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the NDC code 63304-089-13 and lot numbers listed in the recall notice.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the U.S.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 30 days after the firm started it.

1. Firm started the recall: Feb 5, 202412. FDA classified it Class II: Feb 23, 202423. Published in FDA’s Enforcement Report: Mar 6, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is there a risk of serious injury from this product?

The recall is for potential medication effectiveness issues, not a risk of serious injury. The danger level is low_risk.

Similar recalls

Other Sun Pharmaceutical recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0350-2024 (February 5, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0350-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA